Zoetis Inc (ZTS)
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Zoetis Inc is a Healthcare company with a market capitalization of $30.42B, a trailing P/E ratio of 12.0, and a dividend yield of 2.06%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $1.53 | $1.62 | -5.6% |
| Q4 2025 | February 12, 2026 | $1.48 | $1.40 | +5.7% |
| Q3 2025 | November 4, 2025 | $1.70 | $1.62 | +4.9% |
| Q2 2025 | August 5, 2025 | $1.76 | $1.61 | +9.3% |
| Q1 2025 | May 6, 2025 | $1.48 | $1.40 | +5.7% |
| Q4 2024 | February 13, 2025 | $1.40 | $1.36 | +2.9% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 18,794,854 | 4.45% | 3.4 | +18.0% |
| June 30, 2026 | 15,923,322 | 3.77% | 1.9 | -1.2% |
| June 15, 2026 | 16,112,155 | 3.81% | 2.4 | +19.7% |
| May 29, 2026 | 13,462,233 | 3.19% | 1.8 | +0.7% |
| May 15, 2026 | 13,366,933 | 3.16% | 1.2 | -9.7% |
| April 30, 2026 | 14,800,585 | 3.37% | 3.8 | +9.6% |
| April 15, 2026 | 13,501,475 | 3.08% | 5.3 | -10.7% |
| March 31, 2026 | 15,115,992 | 3.45% | 3.3 | -3.7% |
Other Drug Manufacturers - Specialty & Generic Stocks
Frequently Asked Questions
What is Zoetis Inc's market cap?
As of August 13, 2026, Zoetis Inc (ZTS) has a market capitalization of $30.42B.
What is Zoetis Inc's P/E ratio?
Zoetis Inc trades at a trailing price-to-earnings (P/E) ratio of 12.0. Its forward P/E is 10.8.
Does Zoetis Inc pay a dividend?
Yes — Zoetis Inc pays a dividend yielding 2.06%, an annual payout of $2.06 per share.
What sector is ZTS in?
Zoetis Inc is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
What is Zoetis Inc's short interest?
As of the July 15, 2026 FINRA settlement, 18,794,854 ZTS shares were sold short, or 4.45% of shares outstanding. Days to cover: 3.4. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Zoetis Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Zoetis Inc reported revenue of $9.47B and net income of $2.67B.
Ask your own questions about ZTS
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.